Pentokey Organy Sees Revenue Surge 152%, But Profit Declines 17% in FY26

CHEMICALS
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Pentokey Organy Sees Revenue Surge 152%, But Profit Declines 17% in FY26
Overview

Pentokey Organy India reported a 152% jump in revenue to ₹2.09 crore for FY26. However, net profit fell 17% to ₹0.20 crore. A Q4 loss and rising expenses are key concerns.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Pentokey Organy India Reports Strong Revenue Growth Amidst Profit Dip

Pentokey Organy India's revenue from operations for the financial year 2026 (FY26) surged by 152% to ₹2.09 crore, up from ₹0.83 crore in FY25. However, the company's Profit After Tax (PAT) saw a decline of 17%, falling to ₹0.20 crore from ₹0.25 crore in the previous year.

Reader Takeaway: Strong revenue growth signals market traction, but margin pressure and quarterly losses need attention.

What just happened

Pentokey Organy (India) Limited announced its audited financial results for the fiscal year ending March 31, 2026. The company reported a significant increase in revenue from operations, reaching ₹2.09 crore (₹209 lakh). Concurrently, Profit After Tax for the period stood at ₹0.2032 crore (₹20.32 lakh).

Why this matters

The substantial revenue growth indicates an expanding market presence and demand for the company's products. However, the concurrent decline in net profit, despite higher sales, highlights potential challenges in cost management or pricing power. The auditors' unmodified opinion provides assurance on the financial statements' accuracy.

The backstory

In FY25, Pentokey Organy had reported revenue from operations of ₹0.83 crore and a PAT of ₹0.25 crore. The current fiscal year shows a significant top-line expansion. The company also received a favorable outcome in tax litigation concerning Assessment Year 2015-16, with the Income Tax Department allowing its appeal on all grounds.

What changes now

The company needs to address the reasons for margin compression, primarily driven by a sharp rise in the purchase of stock-in-trade, which increased from ₹1.05 crore in FY25 to ₹1.93 crore in FY26. Additionally, the company reported a loss of ₹0.1314 crore in the fourth quarter ended March 31, 2026, a shift from a profit in the same quarter last year.

Risks to watch

The primary risk is the increasing cost of goods sold, which is eating into profitability. Investors will also monitor if the company can reverse the quarterly loss trend in the upcoming financial periods.

Peer comparison

(No peer comparison data available in the filing).

Context metrics (time-bound)

  • FY 2026 Revenue: ₹2.09 crore (+152% YoY)
  • FY 2026 PAT: ₹0.20 crore (-17% YoY)
  • Q4 FY26 Loss: ₹0.1314 crore
  • Purchase of Stock-in-Trade (FY26): ₹1.93 crore

What to track next

Investors should closely watch the company's strategies to improve cost efficiencies and profitability in the next fiscal year. The ability to translate revenue growth into bottom-line improvement will be crucial.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.